Corrigendum to “Mitochondria-targeted manganese-based mesoporous silica nanoplatforms trigger cGAS-STING activation and sensitize anti PD-L1 therapy in triple-negative breast cancer” [Acta Biomaterialia 199 (2025) 374–386]

Acta Biomaterialia 2026

View at publisher

Authors: Nan Zhong, Ziyue Zu, Yishi Lu, Xuan Sha, Yang Li, Yang Liu, Shangyu Lu, X. M. Luo, Yan Zhou, Jun Tao, Feiyun Wu, Zhaogang Teng

+2 more

Yuxia Tang, Shouju Wang

DOI: 10.1016/j.actbio.2026.01.008

Cited by: 0

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Cancer Immunotherapy and Biomarkers Nanoparticle-Based Drug Delivery